{
    "root": "f1c1a9ec-5375-4b22-892b-9e728a5c86d4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": "Tamsulosin Hydrochloride",
    "value": "20250127",
    "ingredients": [
        {
            "name": "TAMSULOSIN HYDROCHLORIDE",
            "code": "11SV1951MR"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER",
            "code": "NX76LV5T8J"
        },
        {
            "name": "ETHYLCELLULOSE",
            "code": "7Z8S9VYZ4B"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        }
    ],
    "indications": "tamsulosin hydrochloride capsules indicated treatment signs symptoms benign prostatic hyperplasia ( bph ) [ ( 14 ) ] . tamsulosin hydrochloride capsules indicated treatment hypertension .",
    "contraindications": "tamsulosin hydrochloride capsules 0.4 mg daily recommended dose treatment signs symptoms bph . administered approximately one-half hour following meal day . tamsulosin hydrochloride capsules crushed , chewed opened . patients fail respond 0.4 mg dose 2 4 weeks dosing , dose tamsulosin hydrochloride capsules increased 0.8 mg daily . tamsulosin hydrochloride capsules 0.4 mg used combination strong inhibitors cyp3a4 ( e.g . , ketoconazole ) [ ( 5.2 ) ] . tamsulosin hydrochloride capsules discontinued interrupted several days either 0.4 mg 0.8 mg dose , therapy started 0.4 mg once-daily dose .",
    "warningsAndPrecautions": "tamsulosin hydrochloride capsules 0.4 mg supplied high density polyethylene bottles containing 100 capsules size \u201c 2 \u201d hard gelatin capsule white opaque cap black ink white opaque body 0.4 mg black ink , filled white white spherical pellets . tamsulosin hydrochloride capsules 0.4 mg bottles 90 \u2019 : ndc 72865-282-90 bottles 100 \u2019 : ndc 72865-282-01 bottles 500 \u2019 : ndc 72865-282-05 store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c - 30\u00b0c ( 59\u00b0f - 86\u00b0f ) [ usp controlled room temperature ] . keep tamsulosin hydrochloride capsules medicines reach children .",
    "adverseReactions": "tamsulosin hydrochloride capsules contraindicated patients known hypersensitive tamsulosin hydrochloride component tamsulosin hydrochloride capsules . included skin rash , urticaria , pruritus , angioedema , respiratory symptoms [ ( 6.2 ) ] .",
    "indications_original": "Tamsulosin hydrochloride capsules\u00a0are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14)]. Tamsulosin hydrochloride capsules\u00a0are not indicated for the treatment of hypertension.",
    "contraindications_original": "Tamsulosin hydrochloride capsules 0.4 mg once daily\u00a0is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.\n                  \n                  For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)]. \n                      If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.",
    "warningsAndPrecautions_original": "Tamsulosin hydrochloride capsules 0.4 mg are supplied in high density polyethylene bottles containing 100 capsules in size \u201c2\u201d hard gelatin capsule with white opaque cap with AS in black ink and white opaque body with 0.4 mg in black ink, filled with white to off white spherical pellets.\n                  Tamsulosin hydrochloride capsules 0.4 mg\n                  Bottles of 90\u2019s: NDC 72865-282-90\n                  Bottles of 100\u2019s: NDC 72865-282-01\n                  Bottles of 500\u2019s: NDC 72865-282-05\n                  \n                     Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C - 30\u00b0C (59\u00b0F - 86\u00b0F) [see USP Controlled Room Temperature].\n                  Keep tamsulosin hydrochloride capsules and all medicines out of reach of children.",
    "adverseReactions_original": "Tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules. Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms [see Adverse Reactions (6.2)]."
}